Multiple Sclerosis and Related Disorders

Multiple Sclerosis and Related Disorders

Natalizumab improves mental and social health in a real-world MS cohort 3:53
Natalizumab improves mental and social health in a real-world MS cohort
Carrie Hersh • 3 May 2021
MS PATHS: clinical outcomes of underrepresented minority patients with MS 4:05
MS PATHS: clinical outcomes of underrepresented minority patients with MS
Carrie Hersh • 3 May 2021
The impact of the gut microbiota on clinical features in progressive MS 1:13
The impact of the gut microbiota on clinical features in progressive MS
Tanuja Chitnis • 26 Apr 2021
Addressing symptom management in MS 1:50
Addressing symptom management in MS
Carrie Hersh • 3 May 2021
Accelerating systematic learning with MS PATHS 3:42
Accelerating systematic learning with MS PATHS
Carrie Hersh • 3 May 2021
Severe COVID-19 in pediatric MS patients 1:11
Severe COVID-19 in pediatric MS patients
Tanuja Chitnis • 26 Apr 2021
Neurofilament light chain as a biomarker in pediatric MS 0:53
Neurofilament light chain as a biomarker in pediatric MS
Tanuja Chitnis • 26 Apr 2021
Managing pediatric MS in the current era 1:46
Managing pediatric MS in the current era
Tanuja Chitnis • 26 Apr 2021
Early predictors of long-term disability in pediatric MS 4:46
Early predictors of long-term disability in pediatric MS
Ermelinda de Meo • 23 Apr 2021
Predictive and prognostic biomarkers for pediatric MOGAD and NMOSD 3:04
Predictive and prognostic biomarkers for pediatric MOGAD and NMOSD
Brenda Banwell • 26 Apr 2021
Population-based studies are needed for patients with MS & COVID-19 1:29
Population-based studies are needed for patients with MS & COVID-19
Afagh Garjani • 26 Apr 2021
Update on pediatric NMOSD and MOGAD 3:47
Update on pediatric NMOSD and MOGAD
Brenda Banwell • 26 Apr 2021
The impact of COVID-19 in the UK MS Register COVID-19 prospective cohort study 5:36
The impact of COVID-19 in the UK MS Register COVID-19 prospective cohort study
Afagh Garjani • 26 Apr 2021
Identifying cognitive phenotypes in multiple sclerosis 3:47
Identifying cognitive phenotypes in multiple sclerosis
Ermelinda de Meo • 23 Apr 2021
Progress in the multiple sclerosis field: progressive MS 2:02
Progress in the multiple sclerosis field: progressive MS
Ermelinda de Meo • 23 Apr 2021
COVID-19 & MS at AAN 2021 2:15
COVID-19 & MS at AAN 2021
Afagh Garjani • 26 Apr 2021
The content of VJNeurology is intended for healthcare professionals